Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
about
Detection of progesterone receptor forms A and B by immunohistochemical analysisEpidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomesEGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancerProgesterone action in breast, uterine, and ovarian cancers.Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancerGrowth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305.Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.Molecular profiles of progesterone receptor loss in human breast tumors.Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients.Simultaneous targeting of estrogen receptor and HER2 in breast cancer.Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels.Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: an updated meta-analysis.Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling.Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative.Familial and sporadic breast cancers: differences in clinical, histopathological, and immunohistochemical features.
P2860
Q28345003-0EB71F54-767C-4CE4-9307-0D61F32F0CF6Q33691211-09C7F23C-604C-4E72-9503-E93FDC9A9915Q33793142-29136153-9D1A-4E5E-8C89-E365D597E5B4Q33801131-3BC4939B-83A0-489F-9762-C413D4516671Q35108906-8D56EA5C-0970-4811-BC77-9303FB67EBFEQ35120828-47FADA51-9B43-465C-AD73-BBB09E1B9B17Q35786706-B53FFAF0-B8F5-40E0-A03F-AA9D24E161EAQ36860992-87F55002-52E4-4A60-937E-2FCF12C9D44AQ37083949-A326CBD8-5EE1-4FC9-BF29-E81484478AD3Q37607412-9F6258BF-65B6-4C6E-954B-DF18C9DFA89CQ37782093-D513064B-5FA8-4B81-B44C-72AA74996870Q38456582-15328E4C-08F2-4D6D-A7BD-48EC156D1614Q38785352-85C6CD01-43B8-430D-98A9-2E54855883FDQ46689580-F761AA63-41E3-433F-BC97-1E087339C9D9Q47103005-26D6E21E-047B-48B5-8BF3-3AC012D96EFFQ50053097-5F958812-0D58-4800-95A6-A23B5A23BFD3Q54293477-42C1603E-A8CB-470A-B05B-8452CF77470AQ54685239-54D370E7-9511-440F-B269-ABCC910A8CDA
P2860
Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Absence of progesterone recept ...... ancer in postmenopausal women.
@ast
Absence of progesterone recept ...... ancer in postmenopausal women.
@en
type
label
Absence of progesterone recept ...... ancer in postmenopausal women.
@ast
Absence of progesterone recept ...... ancer in postmenopausal women.
@en
prefLabel
Absence of progesterone recept ...... ancer in postmenopausal women.
@ast
Absence of progesterone recept ...... ancer in postmenopausal women.
@en
P2093
P2860
P356
P1476
Absence of progesterone recept ...... ancer in postmenopausal women.
@en
P2093
Balleine RL
Greenberg ML
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690249
P407
P577
1999-03-01T00:00:00Z
P5875
P6179
1015710257